A global biopharmaceutical and clinical manufacturing company sought to expand operations into the U.S. market. With no prior U.S.-focused messaging, strategy, or digital presence in place, they needed a partner who understood both the complexity of the bioscience sector and the specific demands of the American market.
The company engaged Bracken for a comprehensive go-to-market strategy — one that could establish credibility, generate leads, and build a foundation for long-term U.S. growth in a highly specialized industry.
What Made U.S. Market Entry Difficult
Entering the U.S. market with no established messaging, no digital footprint, and no domestic brand presence — in one of the most competitive sectors in life science.
No prior U.S.-focused messaging, value proposition, or go-to-market strategy existed
Previous marketing partners outside life sciences lacked the domain understanding required for credible positioning
Brand identity needed to communicate clearly to a U.S. audience without losing global identity
Stakeholder resistance to branding changes required careful, expert navigation
The dual challenge of building awareness and generating convertible leads simultaneously, in a specialized industry
How Bracken Built the U.S. Presence
A multi-tiered campaign spanning strategic messaging, digital marketing, paid media, and marketing asset development — all grounded in deep life science domain expertise.
Market Assessment
Conducted an in-depth analysis of the competitive landscape, identified key U.S. market opportunities, and developed a targeted go-to-market strategy that emphasized the company's strengths and positioned it as a credible leader
Messaging Development
Created a U.S.-specific value proposition, service descriptions, and elevator pitch — as well as website copy for key pages including homepage and landing pages — tailored to resonate with American life science audiences
Digital & Social Campaigns
Developed LinkedIn posts, ad campaigns, and analytics tracking to refine performance and ensure ROI — alongside design of digital conference panels for increased visibility at industry events
Marketing Asset Build
Produced a capabilities deck, one-pagers on product development and technology transfer, a messaging guide, and an organic social media management program with four monthly posts for consistent brand engagement
Ongoing Optimization
Maintained flexible campaign management — adjusting strategy in real time as client priorities evolved, with close collaboration to ensure tailored solutions that drove measurable results
Measurable Outcomes
Life science marketing isn't one-size-fits-all — and generic agencies can't replicate what Bracken provides. The combination of deep biopharmaceutical domain expertise and full-stack marketing execution is what enabled this client to enter the U.S. market with credibility, generate convertible leads, and build a foundation for sustained growth. When priorities shifted in 2025, Bracken pivoted seamlessly with them.
Common Questions About Life Science Go-To-Market Strategy
A go-to-market (GTM) strategy for a life science company defines how you will reach your target customers, communicate your value proposition, and generate business in a specific market. It covers positioning, messaging, channel selection, content, and sales enablement — all tailored to the specific regulatory, scientific, and commercial context of the life science sector.
U.S. market entry is challenging for life science companies because the competitive landscape is dense, buyer sophistication is high, and credibility signals matter enormously. Generic marketing doesn't work — U.S. biopharma and biotech buyers expect partners who understand their specific challenges, regulatory environment, and technical requirements. Companies entering without deep domain knowledge in their messaging often fail to establish trust quickly enough to convert leads.
With a well-executed GTM strategy, a life science company can begin generating high-quality leads within 3–6 months of launch. The timeline depends on digital infrastructure, content quality, and campaign execution. Bracken's integrated approach — combining messaging development, digital campaigns, and paid media — is designed to build momentum quickly while establishing long-term brand authority.
Bracken brings the rare combination of deep life science domain expertise and full-stack marketing execution. Unlike general agencies that require extensive onboarding to understand the industry, Bracken's team has worked inside clinical development, regulatory affairs, and biopharma operations — which means messaging is scientifically credible and strategically aligned from day one. This is what allows Bracken to generate results that generic agencies cannot replicate.
